Webb G A, Lagios M D
Am J Obstet Gynecol. 1987 Jun;156(6):1486-91. doi: 10.1016/0002-9378(87)90021-4.
In a clinical-pathologic review of 825 cases of endometrial carcinoma diagnosed between 1955 and 1984, 735 cases were confirmed as endometrial carcinoma. From this group 29 cases of clear cell carcinoma of the endometrium were found representing a 4% frequency. Clear cell carcinoma of the endometrium was found in an older group of women, all postmenopausal. No relationship to the use of estrogen could be demonstrated. The frequency of clear cell carcinoma of the endometrium dropped from 6% in the group diagnosed between 1955 and 1969 to 3% in the group diagnosed between 1970 and 1984, although the numbers of cases of endometrial cancer rose from 194 to 525 in the comparative time span. Clear cell carcinoma of the endometrium has a poorer prognosis, with a 64% 5-year survival rate compared with an 80% 5-year survival rate for adenocarcinoma, not otherwise stated. Three patients died after 5 years of disease. Treatment is still not satisfactory, but the proved therapy remains total abdominal hysterectomy plus salpingo-oophorectomy. The role of adjunctive therapy has not been established.
在一项对1955年至1984年间诊断的825例子宫内膜癌病例的临床病理回顾中,735例被确诊为子宫内膜癌。在这组病例中,发现29例子宫内膜透明细胞癌,占比4%。子宫内膜透明细胞癌多见于老年女性,均为绝经后女性。未发现与雌激素使用有关。子宫内膜透明细胞癌的发生率从1955年至1969年诊断的病例组中的6%降至1970年至1984年诊断的病例组中的3%,尽管在比较的时间段内子宫内膜癌病例数从194例增至525例。子宫内膜透明细胞癌的预后较差,5年生存率为64%,而未另作说明的腺癌5年生存率为80%。3例患者在患病5年后死亡。治疗仍不尽人意,但已证实的疗法仍是全腹子宫切除术加双侧输卵管卵巢切除术。辅助治疗的作用尚未确立。